Detailed information for compound 1780881

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 567.635 | Formula: C32H33N5O5
  • H donors: 2 H acceptors: 5 LogP: 3.82 Rotable bonds: 8
    Rule of 5 violations (Lipinski): 2
  • SMILES: C=CCn1c(=O)c(cc2c1ccc(c2)C)C1C(=C(N)N(C2=C1C(=O)CC(C2)(C)C)NC(=O)c1ccncc1)C(=O)OC
  • InChi: 1S/C32H33N5O5/c1-6-13-36-22-8-7-18(2)14-20(22)15-21(30(36)40)25-26-23(16-32(3,4)17-24(26)38)37(28(33)27(25)31(41)42-5)35-29(39)19-9-11-34-12-10-19/h6-12,14-15,25H,1,13,16-17,33H2,2-5H3,(H,35,39)
  • InChiKey: KKVNHMAOPLVKLF-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Onchocerca volvulus DNA topoisomerase 2 homolog 0.0559 0.2036 1
Trypanosoma cruzi DNA topoisomerase II, putative 0.0396 0.1249 0.2097
Brugia malayi Probable DNA topoisomerase II 0.0559 0.2036 1
Chlamydia trachomatis DNA gyrase subunit B 0.1496 0.655 0.6507
Echinococcus multilocularis atpase aaa+ type core atpase aaa type core 0.0656 0.2502 1
Plasmodium vivax DNA topoisomerase II, putative 0.0559 0.2036 0.1935
Trypanosoma brucei DNA topoisomerase II alpha, putative 0.0396 0.1249 0.2097
Toxoplasma gondii ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein 0.1249 0.5359 1
Echinococcus granulosus DNA topoisomerase 3 alpha 0.0163 0.0125 0.0615
Trypanosoma brucei DNA topoisomerase II beta, putative 0.0396 0.1249 0.2097
Loa Loa (eye worm) TOPoisomerase family member 0.0559 0.2036 1
Mycobacterium ulcerans DNA gyrase subunit A 0.0253 0.0559 0.0439
Giardia lamblia DNA topoisomerase II 0.0488 0.1691 1
Echinococcus multilocularis rho GTPase activating protein 20 0.0163 0.0125 0.05
Plasmodium falciparum DNA topoisomerase 2 0.0559 0.2036 0.1935
Trypanosoma brucei DNA topoisomerase ii 0.1275 0.5485 1
Toxoplasma gondii DNA gyrase/topoisomerase IV, A subunit domain-containing protein 0.0253 0.0559 0.0829
Trichomonas vaginalis DNA topoisomerase II, putative 0.0559 0.2036 1
Plasmodium falciparum DNA gyrase subunit B 0.2212 1 1
Loa Loa (eye worm) hypothetical protein 0.037 0.1123 0.5222
Schistosoma mansoni prokaryotic DNA topoisomerase 0.0163 0.0125 0.0615
Toxoplasma gondii DNA topoisomerase 2, putative 0.0559 0.2036 0.3651
Echinococcus granulosus DNA topoisomerase 3 beta 1 0.0163 0.0125 0.0615
Leishmania major mitochondrial DNA topoisomerase II 0.1275 0.5485 1
Schistosoma mansoni prokaryotic DNA topoisomerase 0.0163 0.0125 0.0615
Onchocerca volvulus DNA topoisomerase 2 homolog 0.0559 0.2036 1
Loa Loa (eye worm) hypothetical protein 0.037 0.1123 0.5222
Trypanosoma cruzi DNA topoisomerase II, putative 0.0396 0.1249 0.2097
Wolbachia endosymbiont of Brugia malayi DNA gyrase, topoisomerase II, B subunit, GyrB 0.2212 1 1
Wolbachia endosymbiont of Brugia malayi DNA gyrase subunit A 0.0253 0.0559 0.0439
Plasmodium falciparum DNA gyrase subunit A 0.0253 0.0559 0.0439
Mycobacterium ulcerans DNA gyrase subunit B 0.2212 1 1
Leishmania major DNA topoisomerase ii 0.0396 0.1249 0.2097
Brugia malayi DNA gyrase/topoisomerase IV, A subunit family protein 0.0559 0.2036 1
Treponema pallidum DNA gyrase, subunit A (gyrA) 0.0253 0.0559 0.0439
Echinococcus multilocularis DNA topoisomerase 2 alpha 0.0559 0.2036 0.8135
Chlamydia trachomatis DNA gyrase subunit A 0.0253 0.0559 0.0439
Onchocerca volvulus Putative DNA topoisomerase 2, mitochondrial 0.0559 0.2036 1
Entamoeba histolytica DNA topoisomerase II, putative 0.0559 0.2036 1
Trypanosoma cruzi mitochondrial DNA topoisomerase II, putative 0.1275 0.5485 1
Treponema pallidum DNA gyrase, subunit B (gyrB) 0.2212 1 1
Plasmodium vivax DNA gyrase subunit B, putative 0.2212 1 1
Mycobacterium tuberculosis DNA gyrase (subunit B) GyrB (DNA topoisomerase (ATP-hydrolysing)) (DNA topoisomerase II) (type II DNA topoisomerase) 0.2212 1 1
Mycobacterium leprae Probable DNA gyrase (subunit B) GyrB (DNA topoisomerase (ATP-hydrolysing)) (DNA topoisomerase II) (Type II DNA topoisomerase) 0.0716 0.2789 1
Echinococcus multilocularis DNA topoisomerase 3 beta 1 0.0163 0.0125 0.05
Schistosoma mansoni DNA topoisomerase II 0.0559 0.2036 1
Trypanosoma cruzi mitochondrial DNA topoisomerase II, putative 0.1275 0.5485 1
Echinococcus granulosus DNA topoisomerase 2 alpha 0.0559 0.2036 1
Plasmodium vivax DNA gyrase subunit A, putative 0.0253 0.0559 0.0439
Brugia malayi DNA topoisomerase II, alpha isozyme 0.0559 0.2036 1

Activities

Activity type Activity value Assay description Source Reference
GI (functional) = 99 % Antituberculosis activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition at 250 ug/ml after 12 to 28 days by Lowenstein-Jensen method relative to control ChEMBL. 23747804
MIC (functional) = 25 ug ml-1 Antituberculosis activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 12 to 28 days by Lowenstein-Jensen method ChEMBL. 23747804
MIC (functional) = 125 ug ml-1 Antibacterial activity against Escherichia coli MTCC 443 assessed as growth inhibition by broth microdilution method ChEMBL. 23747804
MIC (functional) = 500 ug ml-1 Antifungal activity against Candida albicans MTCC 227 assessed as growth inhibition by broth microdilution method ChEMBL. 23747804

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.